Publication at First Faculty of Medicine |
2016
Abstract
In our recent publication, we noted a borderline association of the truncating variant c.1096_1099dupATTA in the FANCL gene with increased breast cancer (BC) risk in high-risk BRCA1/BRCA2/PALB2-negative BC patients. However, the subsequent analysis by Pfeifer et al. genotyping the c.1096_1099dupATTA variant in 2370 samples from German and Macedonian BC patients and controls failed to confirm association of this variant with BC risk.